Original Research Article
Year: 2021 | Month: December | Volume: 11 | Issue: 12 | Pages: 91-95
DOI: https://doi.org/10.52403/ijhsr.20211214
Therapeutic Role of Shwasa Kuthar Rasa in the Management of Tamaka Shwasa (Bronchial Asthma): A Single Group Randomized Clinical Trial
Archana Verma1, Meenu Mishra2, Raju Ninama3, Rajesh Meshram4
1,2Post Graduate Scholar Kayachikitsa
3Post Graduate Scholar Ras-shastra and Bhaishajya Kalpana
4Reader & H.O.D. Department of Kayachikitsa
Pt. Khushilal Sharma Govt.(Auto.) Ayurveda College and Institute, Bhopal, Madhya Pradesh, India
Corresponding Author: Archana Verma
ABSTRACT
Background: Bronchial Asthma is a disease of airways that is characterized by hyper-responsiveness of the tracheobronchial tree to a variety of stimuli resulting in widespread spasmodic narrowing of the airway. According to WHO 2016, Asthma affects 235 million people worldwide, out of which 15-20 million people are from India. In India, the prevalence of self-reported asthma is 2% among women aged 15-49 years and 1% among young women aged 15-19 years as well as men aged 15-49 years as per the latest report. Prevalence of asthma is more in urban areas than rural area as due to smoke, pollution and environmental factor. In Ayurveda Bronchial Asthma has a high resemblance with Tamaka Shwasa which comes under Pranavaha Srotas. It is described in Brihatrayee as well as Laghutrayee. Acharya Charak and Sushruta has given detailed description of Tamaka Shwasa.
Aim and Objectives: To study the effect of shwasa kuthar rasa in the management of (bronchial asthma) and to find out an effective Ayurvedic medicine for Tamaka Shwasa (Bronchial Asthma). Material and
Methods: For this open clinical study, 10 patients of Tamak Shwasa (bronchial asthma) were registered from OPD of Kayachikitsa department and admitted in IPD of Pt. Khushilal Govt (Auto.) Ayurveda Hospital Bhopal. The patient was treated with Shwasa Kuthar Rasa. Duration of study was 30 days and follow up was done after completion of trial every week for 1 month, assessment was done on the basis of symptomatic relief and increase the range of FEV1 and FVC value after treatment.
Observation: yielded symptomatic relief after treatment. The overall effect of the treatment in patient suggested that, there is 87.50 % relief in cough (Kasa), 90.01% relief in dyspnoea (Shwasakashta), 93.37% relief in chest tightness (Urashool) and 74.99% relief in wheezing (Ghurghurak) and value of FEV1 and FVC were increased up to 22.29% & 24.43% after treatment.
Conclusion: On the basis of result obtained, it can be concluded that Shwasa Kuthar Rasa can be used as an effective medicine in the management of (Bronchial asthma).
Key words: Tamaka Shwasa, Bronchial Asthma, Shwasa Kuthar Rasa.